HKHiroki Kitaura

Hiroki Kitaura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hiroki Kitaura has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Akiyoshi Kakita

    Department of Pathology, Brain Research Institute, Niigata University , Niigata

    1 shared publication
  • Haruki Kuwamura

    Department of Disease Model, Institute for Developmental Research Aichi Developmental Disability Center Kasugai Aichi Japan

    1 shared publication
  • Kazuki Shibata

    Pharmacology Research Unit Sumitomo Pharma Co., Ltd. Osaka Japan

    1 shared publication
  • Keitaro Yamada

    Department of Pediatric Neurology, Central Hospital Aichi Developmental Disability Center Kasugai Aichi Japan

    1 shared publication
  • Kimihiro Kimura

    Pharmacology Research Unit Sumitomo Pharma Co., Ltd. Osaka Japan

    1 shared publication
  • Machiko Iida

    Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan; Department of Disease Model, Institute For Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, Japan

    1 shared publication

Latest Publications

  • Open Access

    Girdin deficiency causes developmental and epileptic encephalopathy with hippocampal sclerosis and interneuronopathy

    by Machiko Iida, Motoki Tanaka, Tsuyoshi Takagi, Tohru Matsuki, Kimihiro Kimura, Kazuki Shibata, Yohei Kobayashi, Yuka Mizutani, Haruki Kuwamura, Keitaro Yamada, et al.

    Objective: Loss‐of‐function mutations in the GIRDIN/CCDC88A gene cause developmental epileptic encephalopathy (DEE) in humans. However, its pathogenesis is largely unknown. Global knockout mice of the corresponding orthologous gene (gKOs) have a preweaning lethal phenotype with growth failure, preventing longitudinal analysis. We aimed to overcome this lethality and elucidate DEE pathogenesis.Methods: We developed a novel lifelong feeding regimen (NLFR), which consists of providing mash food from postnatal day 14 (P14) until weaning (P28), followed by agar‐bound food exclusively after weaning. Videography, electroencephalography (EEG), and histological analyses were performed. Conditional Girdin/Ccdc88a knockout mice (cKOs) of variable lineages (Nestin, Emx1, or Nkx2‐1) were generated to identify the region responsible for epilepsy.Results: Under the NLFR, gKOs survived beyond 1 year and displayed fully penetrant, robust epileptic phenotypes, including early‐onset (P22.3 in average) generalized tonic–clonic seizures (GTCSs) (averaging eight per day), which were completely synchronized with fast rhythms on EEG, frequent interictal electroencephalographic spikes (averaging 430 per hour), and progressive deformation of visceral organs. In addition, gKOs had absence seizures, which were not always time‐locked to frequent spike waves on EEG. The frequent GTCSs and interictal spikes in gKOs were suppressed by known antiepileptic drugs. Histologically, bilateral hippocampi in gKOs exhibited congenital cornu‐ammonis splitting, granule cell dispersion, and astrogliosis. Furthermore, analysis of conditional knockouts using multiple Cre‐deleters identified a defect in the delivery of interneuron precursors from the medial ganglionic eminence into the hippocampal primordium during embryogenesis as a major cause of epileptogenesis.Significance: These findings give rise to a new approach of lifelong caregiving to overcome the problem of preweaning lethality in animal models. We propose a useful model for studying DEE with hippocampal sclerosis and interneuronopathy. gKOs with NLFR combine the contradictory properties of robust epileptic phenotypes and long‐term survivability, which can be used to investigate spontaneous epileptic wave propagation and therapeutic intervention in hippocampal sclerosis.